LFCR Insider Trading

83.36% of Lifecore Biomedical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Lifecore Biomedical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Legion Partners Asset Management LLC	2,968,409	$15.23M	4.7%	+0.6%	9.790%
8/14/2024	272 Capital LP	23,478	$0.12M	0.1%	-83.9%	0.077%
8/14/2024	Marshall Wace LLP	300,120	$1.54M	0.0%	+87.3%	0.990%
8/13/2024	DCF Advisers LLC	290,684	$1.49M	0.8%	+2.1%	0.959%
8/9/2024	Renaissance Technologies LLC	11,000	$56K	0.0%	N/A	0.036%
8/8/2024	American Century Companies Inc.	31,982	$0.16M	0.0%	-46.2%	0.105%
8/2/2024	Allegheny Financial Group LTD	10,085	$52K	0.0%	N/A	0.033%
8/1/2024	Rhumbline Advisers	26,899	$0.14M	0.0%	+1,668.5%	0.088%
7/26/2024	Bank of New York Mellon Corp	63,776	$0.33M	0.0%	N/A	0.210%
5/28/2024	Boston Partners	19,674	$0.10M	0.0%	N/A	0.065%
5/10/2024	Vanguard Group Inc.	1,184,856	$6.29M	0.0%	-12.3%	3.908%
5/10/2024	Tocqueville Asset Management L.P.	351,700	$1.87M	0.0%	-12.4%	1.160%
5/9/2024	State Board of Administration of Florida Retirement System	21,544	$0.11M	0.0%	N/A	0.071%
5/7/2024	Cove Street Capital LLC	1,283,780	$6.82M	2.2%	+41.0%	4.234%
5/7/2024	Oppenheimer Asset Management Inc.	43,001	$0.23M	0.0%	+79.9%	0.142%
5/7/2024	SG Americas Securities LLC	10,659	$57K	0.0%	N/A	0.035%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	10,860	$58K	0.0%	N/A	0.036%
4/30/2024	Cutter & CO Brokerage Inc.	10,767	$57K	0.0%	-30.8%	0.036%
2/15/2024	Greenhaven Road Investment Management L.P.	2,366,956	$14.65M	6.6%	+7.9%	7.806%
2/14/2024	Visionary Wealth Advisors	497,204	$3.08M	0.2%	-0.8%	1.640%
2/13/2024	DCF Advisers LLC	259,684	$1.61M	0.9%	+115.1%	0.856%
2/12/2024	Cove Street Capital LLC	910,264	$5.64M	1.7%	-17.7%	3.002%
2/1/2024	Cutter & CO Brokerage Inc.	15,567	$96K	0.0%	-28.3%	0.051%
1/30/2024	Keene & Associates Inc.	21,935	$0.14M	0.1%	-8.4%	0.072%
12/6/2023	Citigroup Inc.	33,618	$0.25M	0.0%	+2,311.6%	0.111%
11/21/2023	Greenhaven Road Investment Management L.P.	2,193,333	$16.55M	8.4%	+15.3%	7.234%
11/14/2023	Trexquant Investment LP	47,157	$0.36M	0.0%	N/A	0.156%
11/13/2023	Visionary Wealth Advisors	501,334	$3.78M	0.3%	+0.4%	1.653%
11/9/2023	HAP Trading LLC	163,773	$1.24M	0.2%	-82.6%	0.540%
11/9/2023	Cove Street Capital LLC	1,105,556	$8.35M	2.8%	-31.7%	3.646%
11/9/2023	Tocqueville Asset Management L.P.	401,700	$3.03M	0.1%	-11.1%	1.325%
11/8/2023	Oppenheimer Asset Management Inc.	33,532	$0.25M	0.0%	-48.4%	0.111%
11/7/2023	Barclays PLC	30,911	$0.23M	0.0%	+244.8%	0.102%
11/7/2023	Jump Financial LLC	36,918	$0.28M	0.0%	N/A	0.122%
11/6/2023	Assenagon Asset Management S.A.	23,852	$0.18M	0.0%	-68.4%	0.079%
10/24/2023	Bank of New York Mellon Corp	24,615	$0.19M	0.0%	-7.9%	0.081%
9/21/2023	Barclays PLC	8,965	$87K	0.0%	N/A	0.030%
8/15/2023	Corsair Capital Management L.P.	122,431	$1.18M	0.4%	N/A	0.404%
8/11/2023	Cove Street Capital LLC	1,619,536	$15.66M	4.9%	N/A	5.341%
8/11/2023	Visionary Wealth Advisors	499,309	$4.83M	0.4%	N/A	1.647%
8/10/2023	Gamco Investors INC. ET AL	76,500	$0.74M	0.0%	N/A	0.252%
8/10/2023	Gabelli Funds LLC	16,600	$0.16M	0.0%	N/A	0.055%
8/7/2023	Mirabella Financial Services LLP	15,413	$0.15M	0.0%	N/A	0.051%
8/3/2023	Oppenheimer Asset Management Inc.	64,975	$0.63M	0.0%	N/A	0.214%
8/1/2023	Cutter & CO Brokerage Inc.	21,700	$0.21M	0.1%	N/A	0.072%
7/26/2023	Keene & Associates Inc.	24,100	$0.23M	0.2%	N/A	0.079%
7/25/2023	Assenagon Asset Management S.A.	75,391	$0.73M	0.0%	N/A	0.249%
7/18/2023	Defender Capital LLC.	86,450	$0.84M	0.3%	N/A	0.285%
7/18/2023	Diversified Trust Co	46,062	$0.45M	0.0%	N/A	0.152%
6/1/2023	Prelude Capital Management LLC	21,295	$80K	0.0%	N/A	0.070%

Data available starting January 2016

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Today's Range

Now: $5.09

$4.98

$5.45

50 Day Range

MA: $5.16

$3.82

$6.34

52 Week Range

Now: $5.09

$3.68

$8.90

Volume

131,650 shs

Average Volume

217,383 shs

Market Capitalization

$154.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Lifecore Biomedical?: Lifecore Biomedical's top insider investors include:
Wynnefield Partners Small Cap (Major Shareholder)
Learn More about top insider investors at Lifecore Biomedical.